Opinion & analysis | Page 18 of 20 | Report Store

Pharma Intelligence

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Call Back

Name

Email *

Company name *

Phone number *

Sanofi Prioritizes Cancer And Rare Diseases In Pipeline Shake-Up

Bristol-Myers, Celgene and The Perils Of The US Drug Pricing Environment

New Year Present For Takeda As Shire Close Nears?

Novo Nordisk’s Oral Rybelsus Priced On Par With Injectable GLP-1s, But Big Discounts May Be Needed

EMA To Re-Prioritize Tasks To Cope With ‘Higher Than Expected’ Staff Losses

US FDA’s Temple on Real-world Evidence: “I Find the Whole Thing Very Frustrating”

Modernizing FDA’s Supplement Industry Regulation Mapped Out In Five-Point Plan

Pharma’s New R&D Models: Federating Innovation

Sanofi’s New CEO Paul Hudson Poised To Write The Next Chapter

FDA’s Quality System Regulation Is Mapped To International Standard ISO 13485 – And Vice Versa – In New Report From AAMI

DECIEM, Truly ‘The Abnormal Beauty Company,’ Faces Uncertain Future

Novartis Battens Down Hatches Over Falsified Zolgensma Data

Pfizer Price Increases Underscore Rebate Problem, HHS’ Hargan Says

Farxiga Data Change Heart Failure Treatment Outlook

Eight Talking Points from ESMO